Vilazodone Hydrochloride
Showing 1 - 25 of 1,793
Post Traumatic Stress Disorder Trial (Intervention B Vilazodone Hydrochloride, Intervention B Placebo)
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention B Vilazodone Hydrochloride
- Intervention B Placebo
- (no location specified)
Jul 5, 2023
Post Traumatic Stress Disorder Trial (Intervention A Fluoxetine HCl, Intervention A Placebo, Intervention B Vilazodone
Not yet recruiting
- Post Traumatic Stress Disorder
- Intervention A Fluoxetine HCl
- +3 more
- (no location specified)
Jun 21, 2022
Bipolar Disorder Therapies
Completed
- Bipolar Disorder
- Lithium Carbonate
- +29 more
-
Albuquerque, New MexicoChristophe G Lambert
Sep 29, 2021
Generalized Anxiety Disorder Trial in United States (Placebo, Vilazodone)
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
MDD Trial in United States (Placebo, Vilazodone)
Generalized Anxiety Disorder Trial in United States (Placebo, Vilazodone)
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
-
Mobile, Alabama
- +697 more
Nov 16, 2022
Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)
Recruiting
- Nausea and Vomiting
- Palonosetron hydrochloride capsules
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,
Completed
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Fluorouracil
- +5 more
-
Birmingham, Alabama
- +806 more
Oct 18, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Oxycodone Sustained-release Tablets for Moderate to Severe
Recruiting
- Cancer Pain
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 24, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Knee Osteoarthritis Trial in United Kingdom (Liposomal bupivacaine, Bupivacaine HCl)
Completed
- Knee Osteoarthritis
- Liposomal bupivacaine
- Bupivacaine hydrochloride
-
Birmingham, United Kingdom
- +10 more
Nov 3, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Mitoxantrone Hydrochloride Liposome Injection
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Aug 9, 2022